Professor, HEI, McMaster University

Dr. Lehana Thabane is a Professor in Biostatistics at McMaster University. He is a pioneer in health-research and clinical-trials methodology, celebrated as an academic mentor, and an advocate of evidence-based medicine and health care in Canada and the world. Dr. Thabane was the lead statistician on several trials that won national and international awards for their methodological rigour and impact on health policy and practice. He is dedicated to developing biostatistical expertise in the Sub-Saharan region of Africa and is distinguished by his extraordinary passion and aptitude for ...


Distinguished ProfessorEmerita, University of Saskatchewan

One of Canada's leading nutrition scholars and an internationally recognized authority on vitamin D and calcium supplementation. For over 40 years, Dr. Whiting has conducted research on dietary influences of bone health, effectiveness of nutrient supplements and calcium and vitamin D status. She has served on internationally significant boards and panels such the Institute of Medicine's Committee on Use of Dietary Reference Intakes in Nutrition Labelling and the North American Dietary Supplements Advisory Board. She received the Canadian Nutrition Society Lifetime Achievement Award in 2012. ...


Professor, McGill University

Szyf received his Ph. D from the Hebrew University and did his postdoctoral fellowship in Genetics at Harvard Medical School, joined the department in 1989 and currently holds a James McGill Professorship and GlaxoSmithKline-CIHR Chair in Pharmacology. He is the founding co-director of the Sackler Institute for Epigenetics and Psychobiology at McGill and is a Fellow of the Canadian Institute for Advanced Research Experience-based Brain and Biological Development program. Szyf has been the founder of the first "Pharma" to develop epigenetic pharmacology "Methylgene Inc." and the first journal ...


Dr. Ross E.G. Upshur is recognized for his significant contributions to primary care/family medicine research in Canada, particularly in multi-morbidity and the integration of public health and primary care, for which has been named one of Top 20 Pioneers in Family Medicine Research in Canada. Additionally, Dr. Upshur contributed to the resurgence of public health ethics as an academic discipline particularly with respect to work in ethics and infectious diseases helping Canada and other countries develop their approach to responding to outbreaks of SARS-CoV-2, pandemic influenza and Ebola. ...


Professor Emeritus, University of Guelph

Professor of Neuroendocrinology, Department of Biomedical Sciences at the Ontario Veterinary College, and former President and Vice-Chancellor of the University of Guelph (2003-2014). He earned international acclaim for his discovery of the relaxin-brain connection and the roles of the hormone relaxin in neural function, skeletal muscle blood vessels, tumour growth and metastasis. Received international awards including one for a highly effective method of reducing iron deficiency anemia in women and children in Cambodia. He is conducting research on HIV/AIDS in aboriginal populations and ...


Professor of Neuropharmacology, University of Prince Edward Island

Andrew Tasker is an internationally recognized neuroscientist. He has an extensive publication and presentation record and has acquired over $10 million in research funding. He also holds 6 patents issued or being prosecuted, has trained 16 postgraduate students, and has contributed significantly to both the Canadian Council on Animal Care and to community outreach activities. Dr. Tasker is best known for advancing our understanding of domoic acid (the “PEI mussel toxin”), the development of a neurodevelopmental rat model of epilepsy, and for his contributions within the Canadian Stroke ...


Professor, University of Calgary

Dr. Suzanne Tough 's research on maternal health has led to fundamental changes in prenatal care, and clinical practice. She leads the innovative All Our Babies/Families study; a cohort of over 3000 families followed prospectively for 10 years resulting in a changed understanding of the relationship between early life events, mental health and long-term outcomes. She is a leader in translating evidence to practice, longitudinal research, and mental health. She is a Professor in the Cummings School of Medicine and has held leadership roles as a Scientific Director and Policy Fellow. She has ...


Professor, University of Toronto

Dr. Anna Taddio, Professor, Leslie Dan Faculty of Pharmacy, and Senior Associate Scientist, The Hospital for Sick Children, is internationally recognized for her work related to pain management during medical procedures and the long-term harms of unmitigated pain. Dr. Taddio founded and currently leads a national inter-disciplinary, multi-sectoral team, Help Eliminate Pain in Kids and Adults (HELPinKids&Adults), investigating and promoting evidence-based pain management during vaccination. The World Health Organization adopted the recommendations from Dr. Taddio and her team in its first ...


Professor Mark Tremblay has a Bachelor of Commerce degree in Sports Administration and a Bachelor of Physical and Health Education degree from Laurentian University.His graduate training was from theUniversity of Toronto where he obtained his M.Sc. and Ph.D. from the Department of Community Health with a specialty in Exercise Science. Dr. Tremblay is the Director of Healthy Active Living and ObesityResearch (HALO)at the Children’s Hospital of Eastern Ontario ResearchInstitute and Professor of Pediatrics in the Faculty of Medicine, University of Ottawa. He is a Fellow of the Canadian Society ...


John Wallace has made important contributions to understanding the molecular mechanisms underlying the gastrointestinal ulcers and bleeding caused by aspirin and other nonsteroidal anti-inflammatory drugs. These are widely used drugs, particularly for treating arthritis, but their adverse effects are common and severe. Based on his mechanistic studies, he has designed and developed new hydrogen sulfide-releasing anti-inflammatory drugs that do not produce ulcers or bleeding, and is similarly working on novel drugs for the treatment of other inflammatory conditions, such as Crohn’s disease, ...